Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-03-11 @ 12:56 AM
Study NCT ID:
NCT04214860
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2019-12-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies
Sponsor:
Aprea Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A19-11184
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None